有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 3-[(1S)-1-(3-bromophenyl)sulfanylethyl]aniline | —— | C14H14BrNS |
|
—— | (2S)-2-(3-bromophenyl)sulfanylpropanenitrile | —— | C9H8BrNS |
|
—— | 2-[[5-[(2S)-1,4-dioxan-2-yl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetic acid | —— | C8H10N2O5S |
|
—— | 2-[[5-[(2R)-1,4-dioxan-2-yl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetic acid | —— | C8H10N2O5S |
|
—— | 2-[[5-[(2S)-1,4-dioxan-2-yl]-1H-1,2,4-triazol-3-yl]sulfanyl]acetic acid | —— | C8H11N3O4S |
|
—— | (1R,2S)-2-(3-bromophenyl)sulfanylcycloheptane-1-carbonitrile | —— | C14H16BrNS |
|
—— | 4-(3-bromophenyl)sulfanyl-N'-hydroxybenzenecarboximidamide | —— | C13H11BrN2OS |
|
—— | (2S,6R)-N-[2-(4-chlorophenyl)sulfanylethyl]-2,6-dimethylmorpholine-4-sulfonamide | —— | C14H21ClN2O3S2 |
|
—— | (2R,6R)-N-[2-(4-chlorophenyl)sulfanylethyl]-2,6-dimethylmorpholine-4-sulfonamide | —— | C14H21ClN2O3S2 |
|
—— | methyl (2S)-2-(2-bromophenyl)sulfanylpropanoate | —— | C10H11BrO2S |
|
—— | methyl (2S)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)propanoate | —— | C13H16O4S |
|
—— | 2-[(2,6-dimethylanilino)methylidene]-1-benzothiophen-3-one | —— | C17H15NOS |
|
—— | 4-phenylsulfanyl-N-[(1S,3R)-3-(trifluoromethyl)cyclohexyl]butanamide | —— | C17H22F3NOS |
|
—— | 2-(2-methylphenyl)sulfanyl-N-[(1R,3R)-3-(trifluoromethyl)cyclohexyl]acetamide | —— | C16H20F3NOS |
|
—— | methyl (2R)-2-(2-bromophenyl)sulfanylpropanoate | —— | C10H11BrO2S |
|
—— | (1R)-1-(1-adamantyl)-N-methyl-3-methylsulfonylpropan-1-amine | —— | C15H27NO2S |
|
—— | (1S)-1-(1-adamantyl)-N-methyl-3-methylsulfonylpropan-1-amine | —— | C15H27NO2S |
|
—— | 2-(2-ethyl-1,3-thiazol-4-yl)-N-[(1R)-1-(4-methylsulfanylphenyl)ethyl]acetamide | —— | C16H20N2OS2 |
|
—— | 3-(difluoromethyl)-5-methylsulfanyl-N-[(3-phenylpyrazol-4-ylidene)methyl]-1,2,4-triazol-4-amine | —— | C14H12F2N6S |
|
—— | N-[[3-(4-bromophenyl)pyrazol-4-ylidene]methyl]-3-(difluoromethyl)-5-methylsulfanyl-1,2,4-triazol-4-amine | —— | C14H11BrF2N6S |
|
—— | N-[[3-(4-chlorophenyl)pyrazol-4-ylidene]methyl]-3-(difluoromethyl)-5-methylsulfanyl-1,2,4-triazol-4-amine | —— | C14H11ClF2N6S |
|
—— | 2-[[5-[[3,5-bis(difluoromethyl)pyrazol-1-yl]methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanyl]-N'-[[3-(4-chlorophenyl)pyrazol-4-ylidene]methyl]acetohydrazide | —— | C22H20ClF4N9OS |
|
—— | 4-(1-hydrazinylethylidene)-2-methoxycyclohexa-2,5-diene-1-thione | —— | C9H12N2OS |
|
—— | 2-[hydroxy(phenyl)methylidene]-1-benzothiophen-3-one | —— | C15H10O2S |
|
—— | 2-[(4-bromophenyl)methylideneamino]oxy-N'-[(3-oxo-1-benzothiophen-2-ylidene)methyl]propanehydrazide | —— | C19H16BrN3O3S |
|
—— | 1-[4-[(2S)-6-methyl-2,3-dihydro-1-benzothiophene-2-carbonyl]-1,4-diazepan-1-yl]ethanone | —— | C17H22N2O2S |
|
—— | 5-methyl-3-[[4-[[(2R)-oxolan-2-yl]methyl]-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole | —— | C15H22N6O2S |
|
—— | 5-methyl-3-[[4-[[(2S)-oxolan-2-yl]methyl]-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole | —— | C15H22N6O2S |
|
—— | 3-[(2-fluorophenyl)methylsulfanyl]-6-[2-[(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methylamino]phenyl]-2H-1,2,4-triazin-5-one | —— | C27H21FN6O2S |
|
—— | 2-(2-methylphenyl)sulfanyl-N-[3-[[(2S)-oxolan-2-yl]methoxy]propyl]acetamide | —— | C17H25NO3S |
|
—— | 4-imino-8-(4-methyl-1,2,5-oxadiazol-3-ylidene)-[1,3,5]triazino[2,1-b][1,3,4]thiadiazin-2-amine | —— | C8H8N8OS |
|
—— | 5-ethoxy-2-[(prop-2-enylamino)methylidene]-1-benzothiophen-3-one | —— | C14H15NO2S |
|
—— | N-[(S)-cyclopropyl-(4-methylphenyl)methyl]-2-(1,3-thiazol-2-ylsulfanyl)acetamide | —— | C16H18N2OS2 |
|
—— | N-[(R)-cyclopropyl-(4-methylphenyl)methyl]-2-(1,3-thiazol-2-ylsulfanyl)acetamide | —— | C16H18N2OS2 |
|
—— | N-cyclopentyl-N-[(3R)-1,1-dioxothiolan-3-yl]-2-(1,3-thiazol-2-ylsulfanyl)acetamide | —— | C14H20N2O3S3 |
|
—— | (2R)-N-(1-phenylcyclobutyl)-2-(1,3,4-thiadiazol-2-ylsulfanyl)propanamide | —— | C15H17N3OS2 |
|
—— | 1-methyl-3-(3-phenylsulfanylpropyl)-1-[(1R)-1-thiophen-2-ylethyl]urea | —— | C17H22N2OS2 |
|
—— | N-[(2R)-1-imidazol-1-yl-3,3-dimethylbutan-2-yl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C14H21N5OS2 |
|
—— | (Z)-N-[2-(4-chlorophenyl)sulfanylethyl]-3-pyridin-2-ylprop-2-enamide | —— | C16H15ClN2OS |
|
—— | 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-[(2S)-1-imidazol-1-yl-3-methylbutan-2-yl]acetamide | —— | C12H18N6OS2 |
|
—— | 2-[3-[(4-chlorophenyl)methylsulfanyl]-6-methyl-1,2,4-triazin-5-yl]-N-[(4-methylphenyl)methoxy]ethenamine | —— | C21H21ClN4OS |
|
—— | (3S)-3-(4-methylpyrimidin-2-yl)sulfanyl-3-phenylpropanenitrile | —— | C14H13N3S |
|
—— | (3R)-3-(3-methylphenyl)sulfanyl-3-phenylpropanimidamide | —— | C16H18N2S |
|
—— | (3S)-N'-hydroxy-3-phenyl-3-pyrimidin-2-ylsulfanylpropanimidamide | —— | C13H14N4OS |
|
—— | (3S)-3-(1-methyltetrazol-5-yl)sulfanyl-3-phenylpropanimidamide | —— | C11H14N6S |
|
—— | (3S)-3-(3-methylphenyl)sulfanyl-3-phenylpropanenitrile | —— | C16H15NS |
|
—— | (3S)-3-(3-methylphenyl)sulfanyl-3-phenylpropanimidamide | —— | C16H18N2S |
|
—— | (3S)-3-phenyl-3-(1,3,4-thiadiazol-2-ylsulfanyl)propanenitrile | —— | C11H9N3S2 |
|
—— | (3R)-N'-hydroxy-3-(1-methylpyrazol-4-yl)sulfanyl-3-phenylpropanimidamide | —— | C13H16N4OS |
|
—— | (3R)-3-phenyl-3-thiophen-2-ylsulfanylpropanimidamide | —— | C13H14N2S2 |
|